1523 - Transluminal insertion, management, repositioning, and removal of an intravascular microaxial blood pump (ImpellaŽ), for patients requiring mechanical circulatory support

Page last updated: 11 May 2018

Application Detail

Status

Open

Description of Medical Service

The proposed medical service is for the insertion, removal and or repositioning of an ImpellaŽ ventricular assist device. ImpellaŽ is a transluminal ventricular assist device that is inserted percutaneously or surgically. The device has a small microaxial pump at one end of a thin, flexible catheter that pumps blood from the ventricle, through an inlet area near the tip and expels blood into the ascending aorta/pulmonary artery. The other end of the tube is connected to an automated control system outside the body that controls the pump rate.The ImpellaŽ technology is part of the latest generation of cardiac assist devices and represents a significant advancement in cardiac assist device technology. The device stabilises haemodynamics, unloads the ventricle, augments peak coronary flow, perfuses the end organs and allows for recovery of the native heart. It is indicated for clinical use in cardiology and cardiac surgery for supporting the native heart in patients with reduced ventricular function. Specifically, the ImpellaŽ can help maintain blood flow and blood pressure during high-risk heart procedures (e.g. protected PCI) and when the heart suddenly cannot pump enough blood (e.g. cardiogenic shock).

Description of Medical Condition

ImpellaŽ is indicated for clinical use in cardiology and cardiac surgery to support patients with compromised ventricular function, i.e. patients experiencing advanced heart failure, heart attack (myocardial infarction), cardiogenic shock and undergoing high risk cardiac procedures.Coronary heart disease is the most common form of cardiovascular disease and approximately half of deaths from coronary heart disease result from an acute myocardial infarction (1). An acute myocardial infarction may also result in heart failure. Cardiogenic shock is a life-threatening situation that can develop because of a myocardial infarction, and occurs when the heart’s ability to function causes organs in the body to begin to fail.Heart failure occurs when the heart is unable to maintain strong enough blood flow to meet the body’s needs (2), it is considered advanced when conventional heart therapies and symptom management strategies no longer work and the patient is symptomatic at rest.

Reason for Application

New MBS item/s

Medical Service Type

Therapeutic

Previous Application Number

Not Applicable

Associated Documentation

Application Form

Application Form (Word 1038 KB)
Application Form (PDF 2016 KB)

Consultation Survey

Consultation Survey (Word 508 KB)
Consultation Survey (PDF 307 KB)

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

-

ESC

-

MSAC

-